Evidence map›Paper›PMID 39997194›Full record

ReviewMarine drugs2025

Anticancer Properties of Macroalgae: A Comprehensive Review.

Sara Frazzini, Luciana Rossi

Abstract readReview
In one paragraph

Review in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Anticancer and Antimicrobial Activity ofMolecules (Basel, Switzerland) · 2026
    Article
  5. Review
  6. Anti-Cancer Activity ofMarine drugs · 2025
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sara FrazziniDepartment of Veterinary Medicine and Animal Sciences-DIVAS, University of Milan, via dell'Università 6, 26900 Lodi, Italy.ORCID 0000-0001-8810-0003
Luciana RossiDepartment of Veterinary Medicine and Animal Sciences-DIVAS, University of Milan, via dell'Università 6, 26900 Lodi, Italy.ORCID 0000-0003-1178-4683

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, the exploration of bioactive molecules derived from natural sources has gained interest in several application fields. Among these, macroalgae have garnered significant attention due to their functional properties, which make them interesting in therapeutic applications, including cancer treatment. Cancer constitutes a significant global health burden, and the side effects of existing treatment modalities underscore the necessity for the exploration of novel therapeutic models that, in line with the goal of reducing drug treatments, take advantage of natural compounds. This review explores the anticancer properties of macroalgae, focusing on their bioactive compounds and mechanisms of action. The key findings suggest that macroalgae possess a rich array of bioactive compounds, including polysaccharides (e.g., fucoidans and alginates), polyphenols (e.g., phlorotannins), and terpenoids, which exhibit diverse anticancer activities, such as the inhibition of cell proliferation, angiogenesis, induction of apoptosis, and modulation of the immune system. This review provides an overview of the current understanding of macroalgae's anticancer potential, highlighting the most promising compounds and their mechanisms of action. While preclinical studies have shown promising results, further research is necessary to translate these findings into effective clinical applications.

Indexed as

Antineoplastic AgentsNeoplasmsSeaweedAnimalsApoptosisCell ProliferationHumansPolysaccharidesAntineoplastic AgentsPolysaccharidesanticanceranticarcinogenicbioactive compoundscancerfucoidansimmunotherapymacroalgaephlorotanninsseaweedterpenoids

Identifiers

PMID39997194
PMCPMC11857751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.